Cadila Healthcare trades in green on the bourses

13 Mar 2018 Evaluate

Cadila Healthcare is currently trading at Rs. 394.35, up by 4.95 points or 1.27% from its previous closing of Rs. 389.40 on the BSE.

The scrip opened at Rs. 394.00 and has touched a high and low of Rs. 397.35 and Rs. 379.20 respectively. So far 31109 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 558.00 on 12-Jun-2017 and a 52 week low of Rs. 373.05 on 06-Feb-2018.

Last one week high and low of the scrip stood at Rs. 397.35 and Rs. 376.10 respectively. The current market cap of the company is Rs. 40381.53 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 16.93% and 8.28% respectively.

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Tizanidine Tablets USP in the strengths of 2 mg and 4 mg. The group now has more than 180 approvals and so far has filed over 320 ANDAs since the commencement of the filing process in FY 2003-04.

The drug is used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury and works by helping to relax the muscles. It will be manufactured at the group's formulations manufacturing facility at SEZ in Ahmedabad.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×